Halozyme
HALO
389 hedge funds and large institutions have $4.71B invested in Halozyme in 2023 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 134 increasing their positions, 144 reducing their positions, and 30 closing their positions.
220% more call options, than puts
Call options by funds: $21.5M | Put options by funds: $6.74M
70% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 30
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
6% more capital invested
Capital invested by funds: $4.45B → $4.71B (+$257M)
5% more funds holding
Funds holding: 370 → 389 (+19)
0.26% less ownership
Funds ownership: 93.64% → 93.38% (-0.26%)
7% less repeat investments, than reductions
Existing positions increased: 134 | Existing positions reduced: 144
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$104M |
| 2 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$23.1M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$16.4M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$16.4M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$10.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$39.6M |
| 2 |
Millennium Management
New York
|
-$37.2M |
| 3 |
BlackRock
New York
|
-$19.9M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$18.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$14.2M |
HALO Hedge Fund Activity: Q3 2023 in Review
389 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q3 2023, worth a combined $4.71B — up 5.8% from $4.45B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new HALO positions and 30 closed out — a net gain of 21 holders — while 134 added to existing stakes and 144 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $104M. The largest seller was Citadel Advisors, cutting an estimated $39.6M.
- 389 institutional investors held Halozyme (HALO) as of Q3 2023, up from 370 in Q2 2023.
- Funds reported $4.71B of Halozyme stock for Q3 2023, up 5.8% quarter-over-quarter.
- 51 funds opened new Halozyme positions in Q3 2023 and 30 closed out, a net change of +21 holders.
- The largest Halozyme buyer in Q3 2023 was AllianceBernstein, an estimated $104M added.
- The largest Halozyme seller in Q3 2023 was Citadel Advisors, an estimated $39.6M sold.
Based on aggregated 13F filings for Q3 2023.